Simon J. Hall

Hall received his B.A. in biology in 1983 from Columbia College, Columbia University and his M.D. in 1988 from the Columbia University College of Physicians and Surgeons. His postdoctoral training included an internship and a junior residency in the department of surgery at The Mount Sinai School of Medicine. He was Chief Resident in the Department of Urology at Boston Medical Center and completed a fellowship in uro-oncology at Baylor College of Medicine.

From 1997 until 2001 Hall was the director of the Department of Urology at Elmhurst Hospital in Queens. In 2001, he was named director of the Barbara and Maurice Deane Prostate Health and Research Center at The Mount Sinai Medical Center, and in 2003 he was named Chair of Mount Sinai's Department of Urology. In 2009, he was named the Kyung Hyun Kim, M.D. Chair in Urology.

Hall's area of research is primarily urologic oncology including the diagnosis, evaluation and treatment of prostate cancer, renal cell cancer and urothelial (transitional cell) cancer affecting the kidneys and bladder, with special focus on the use of robotics and the development of minimally invasive treatment options.

{{BLP unreferenced section|date=July 2023}}

• 1993: Golden Filiform Award, Dept. of Urology, Boston University Medical Center
• 1996: F. Brantly Scott Award, Scott Dept. of Urology, Baylor College of Medicine
• 1997: AUA/CaPCURE Award, 2nd Place, Pfizer Scholars in Urology Award
• 1999: Edwin Beer Award in Urology, New York Academy of Medicine
• 2001: Dr. Solomon Silver Award in Clinical Medicine, Mount Sinai School of Medicine

• Autologous PAP-loaded dendritic cell vaccine (APC8015, Provenge) in patients with non-metastatic prostate cancer who experience PSA failure after radical prostatectomy. Sponsor: Denedron Corp, GCO#01-0592.National Institutes of Health {{Cite web|url= http://clinicaltrials.gov/ct2/show/NCT00110526 |title= Gene Therapy for Prostate Cancer That Returns After Radiation Therapy |author= |date=May 10, 2005 | website= |publisher= ClinicalTrials.gov |accessdate= 2010-02-07}}
• Autologous PAP-loaded dendritic cell vaccine (APC8015, Provenge) in patients with hormone refractory disease. Sponsor: Dendreon Corp.National Institutes of Health {{Cite web|url= http://clinicaltrials.gov/ct2/show/NCT00779402 |title= Provenge for the Treatment of Hormone Sensitive Prostate Cancer (PROTECT) |author= |date=October 22, 2008 | website= |publisher= ClinicalTrials.gov |accessdate= 2010-02-07}}
• A Randomized, Multicenter, Single Blind Study in Men with Metastatic Androgen Independent Prostate Cancer to Evaluate Sipuleucel-T Manufactured with Different Concentrations of PA2024 Antigen (P07-2) Sponsor: Dendreon Corp, GCO #08-0813.National Institutes of Health {{Cite web|url= http://clinicaltrials.gov/ct2/show/NCT00715078 |title=To Evaluate Sipuleucel-T Manufactured With Different Concentrations of PA2024 Antigen (ProACT) |author= |date=July 11, 2008 |website= |publisher= ClinicalTrials.gov |accessdate= 2010-02-07}}

Partial list:

• Thompson, TC, Timme, TL, Hall, SJ, and Stapleton, AMF. Perspectives on the Molecular Biology of Prostate Cancer, In Vogelzang, NJ, Scardino, PT, Shipley, WU, and Coffey, DS. (Eds.) Comprehensive Textbook of Genitourinary Oncology, Williams & Wilkins, Baltimore, MD, 1996. {{ISBN|0-7817-4984-0}}.{{Cite journal|title=Spontaneous but not experimental metastatic activities differentiate primary tumor-derived vs metastasis-derived mouse prostate cancer cell lines |doi=10.1023/A:1018499515883 |volume=15 |issue=6 |journal=Clinical & Experimental Metastasis |pages=630–638|year=1997 |last1=Hall |first1=Simon J. |last2=Thompson |first2=Timothy C. |pmid=9344047 |s2cid=1912375 }}
• Hall SJ, Kresina TF, Trauger R, and. Conley BA. Gene Therapy for the Treatment of Cancer, In Kresina TF (Ed.), An Introduction to Molecular Medicine and Gene Therapy, John Wiley & Sons, New York, NY. 2001. {{ISBN|978-0-471-39188-3}}.{{Cite book|title=Wiley InterScience: An Introduction to Molecular Medicine and Gene Therapy |doi=10.1002/0471223875 |year = 2000|isbn = 978-0471391883|last1 = Kresina|first1 = Thomas F.|editor1-first=Thomas F |editor1-last=Kresina }}
• Millikan RE and Hall SJ. New Possibilities in Systemic Treatment for Metastatic Bladder Cancer, In Droller MJ (Ed.), Bladder Cancer: Current Diagnosis and Treatment, Humana Press, Totowa, NJ. p. 393-422, 2001. {{ISBN|0-89603-818-1}}.{{Cite web |url=http://www.mitec.com.au/catalogue/category689/category711/product11094 |title=Bladder Cancer: Current Diagnosis and Treatment |accessdate=2010-02-07 |url-status=dead |archiveurl=https://web.archive.org/web/20050619111253/http://www.mitec.com.au/catalogue/category689/category711/product11094 |archivedate=2005-06-19 }}

Partial list:

• {{cite journal | pmid = 19493260 | doi=10.1111/j.1464-410X.2009.08661.x | volume=104 | issue=11 | title=Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy | date=December 2009 | journal=BJU Int. | pages=1631–6 | last1 = Stock | first1 = RG | last2 = Cesaretti | first2 = JA | last3 = Hall | first3 = SJ | last4 = Stone | first4 = NN| s2cid=28804721 }}
• {{cite journal | pmid = 18596922 | doi=10.1172/JCI34780 | pmc=2441856 | volume=118 | issue=8 | title=KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis | date=August 2008 | journal=J. Clin. Invest. | pages=2711–21 | last1 = Narla | first1 = G | last2 = DiFeo | first2 = A | last3 = Fernandez | first3 = Y |display-authors=etal}}
• {{cite journal | pmid = 17543727 | doi=10.1016/j.ecl.2007.03.009 | volume=36 | issue=2 | title=Hormonal implications in the development and treatment of prostate cancer | date=June 2007 | journal=Endocrinol. Metab. Clin. North Am. | pages=421–34 | last1 = Ip | first1 = C | last2 = Hall | first2 = SJ}}
• {{cite journal | pmid = 17387369 | pmc=1831538 | volume=9 | title=Clinical experience with gene therapy for the treatment of prostate cancer | year=2007 | journal=Rev Urol | pages=S20–8 | last1 = Stanizzi | first1 = MA | last2 = Hall | first2 = SJ| issue=Suppl 1 }}
• {{cite journal | pmid = 19129926 | pmc=2614324 | volume=1 | issue=3 | title=Community-based free prostate cancer screening program | year=2007 | journal=Prog Community Health Partnersh | pages=215–20 | last1 = Jandorf | first1 = L | last2 = Chang | first2 = MS | last3 = Smith | first3 = K | last4 = Florio | first4 = A | last5 = Hall | first5 = SJ | doi=10.1353/cpr.2007.0024}}
• {{cite journal | pmid = 17120384 | doi=10.3200/BMED.32.3.89-96 | pmc=2258456 | volume=32 | issue=3 | title=Perceived risk and worry about prostate cancer: a proposed conceptual model | year=2006 | journal=Behav Med | pages=89–96 | last1 = Schnur | first1 = JB | last2 = DiLorenzo | first2 = TA | last3 = Montgomery | first3 = GH |display-authors=etal}}
• {{cite journal | pmid = 16204083 | doi=10.1158/0008-5472.CAN-05-0436 | volume=65 | issue=19 | title=Targeted elimination of prostate cancer by genetically directed human T lymphocytes | date=October 2005 | journal=Cancer Res. | pages=9080–8 | last1 = Gade | first1 = TP | last2 = Hassen | first2 = W | last3 = Santos | first3 = E |display-authors=etal| doi-access=free | url=https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Targeted_Elimination_of_Prostate_Cancer_by_Genetically_Directed_Human_T_Lymphocytes/22363475/1/files/39807680.pdf }}
• {{cite journal | pmid = 12597906 | volume=7 | issue=2 | title=IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach | date=February 2003 | journal=Mol. Ther. | pages=185–92 | last1 = Selleck | first1 = WA | last2 = Canfield | first2 = SE | last3 = Hassen | first3 = WA |display-authors=etal | doi=10.1016/s1525-0016(02)00040-0| doi-access=free }}
• {{cite journal | pmid = 12559985 | volume=410 | issue=1 | title=C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation | date=February 2003 | journal=Arch. Biochem. Biophys. | pages=134–40 | last1 = Cardozo | first1 = CP | last2 = Michaud | first2 = C | last3 = Ost | first3 = MC |display-authors=etal | doi=10.1016/s0003-9861(02)00680-x}}

{{Reflist|2}}

• [http://www.mountsinai.org The Mount Sinai Hospital homepage]
• [http://www.mssm.edu The Mount Sinai School of Medicine homepage]
• [http://www.mountsinaifpa.org/patient-care/practices/prostate/about-us The Barbara and Maurice Deane Prostate Health and Research Center] at The Mount Sinai Medical Center
• [http://www.mountsinai.org/img/vgn_lnk/Regular%20Content/File/Daily%20News/H/Hall.pdf "Prostate Cancer: A New Look".]{{dead link|date=March 2018 |bot=InternetArchiveBot |fix-attempted=yes }} Katie Charles (March 25, 2009). New York Daily News.
• [http://www.prostatecancercookbook.com/diagnosed-prostate-cancer.php Excerpt] from Dr. Simon J. Hall's Foreword to Eat to Beat Prostate Cancer by David Ricketts. STC Healthy Living, publisher. {{ISBN|1-58479-475-5}}

{{DEFAULTSORT:Hall, Simon J.}}

Category:American cancer researchers

Category:Columbia University Vagelos College of Physicians and Surgeons alumni

Category:Living people

Category:Icahn School of Medicine at Mount Sinai faculty

Category:Year of birth missing (living people)

Category:Columbia College (New York) alumni